<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pelvic organ prolapse in women: Diagnostic evaluation</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pelvic organ prolapse in women: Diagnostic evaluation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pelvic organ prolapse in women: Diagnostic evaluation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tola B Fashokun, MD, FACOG</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rebecca G Rogers, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Linda Brubaker, MD, FACOG</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 27, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H4375792"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Pelvic organ prolapse (POP), the herniation of the pelvic organs to or beyond the vaginal walls, occurs in up to 50 percent of parous women and causes a variety of pelvic, urinary, bowel, and sexual symptoms [<a href="#rid1">1</a>]. POP stage is diagnosed on pelvic examination. A medical history is also important to elicit commonly associated symptoms since treatment of urinary or fecal symptoms is typically coordinated with treatment for POP. Asymptomatic POP may not require treatment.</p><p>The diagnostic evaluation of women with POP is reviewed here.</p><p>An overview of the female pelvic examination, POP, and treatment options are discussed separately and include:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3253.html" rel="external">"The gynecologic history and pelvic examination"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/8072.html" rel="external">"Pelvic organ prolapse in females: Epidemiology, risk factors, clinical manifestations, and management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14212.html" rel="external">"Pelvic organ prolapse in women: Choosing a primary surgical procedure"</a>.)</p><p></p><p>In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. However, we encourage the reader to consider the specific counseling and treatment needs of transmasculine and gender-expansive individuals.</p><p class="headingAnchor" id="H1120849"><span class="h1">CLASSIFICATION OF PELVIC ORGAN PROLAPSE</span><span class="headingEndMark"> — </span>Historically, the severity of prolapse was graded using a variety of imprecise classification systems that were not easily reproduced or communicated in a standard way among clinicians [<a href="#rid2">2</a>]. The Pelvic Organ Prolapse Quantitation system (POP-Q), introduced in 1996, has become the standard classification system [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H1121013"><span class="h2">POP-Q system</span><span class="headingEndMark"> — </span>The POP-Q system is an objective, site-specific system for describing and staging POP in women [<a href="#rid2">2</a>]. The POP-Q system involves quantitative measurements of various points representing anterior, apical, and posterior vaginal prolapse to create a "topographic" map of the vagina. These anatomic points can then be used to determine the stage of the prolapse  (<a class="graphic graphic_figure graphicRef74368" href="/z/d/graphic/74368.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef57450" href="/z/d/graphic/57450.html" rel="external">figure 2</a> and <a class="graphic graphic_table graphicRef72477" href="/z/d/graphic/72477.html" rel="external">table 1</a>) [<a href="#rid2">2,3</a>].</p><p>The POP-Q system is the POP classification system of choice of the International Continence Society (ICS), the American Urogynecologic Society (AUGS), and the Society of Gynecologic Surgeons (SGS) [<a href="#rid3">3</a>]. The American College of Obstetricians and Gynecologists has also recommended its use [<a href="#rid4">4</a>]. It has proven interobserver and intraobserver reliability [<a href="#rid5">5</a>] and is the system used most commonly in the medical literature [<a href="#rid6">6,7</a>]. Intraoperative POP-Q measurements correlate well with preoperative findings, with slightly more prolapse under anesthesia when traction is placed on the POP-Q points [<a href="#rid8">8</a>].</p><p>The S-POP-Q may be an easier classification system to use in routine clinical practice. It was developed by the International Urogynecology Association to provide a less cumbersome examination tool [<a href="#rid9">9</a>]. The S-POP-Q stages prolapse for the anterior and posterior vaginal walls, the apex/cuff of the vagina and the cervix. For women posthysterectomy, there are three stages; for women with an intact uterus there are four. The examination is carried out similarly to the standard POP-Q examination, with a half speculum placed in the vagina to visualize the vaginal walls and cervix. (See <a class="local">'Simplified POP-Q'</a> below.)</p><p>In this topic, classification of POP will be described using the original POP-Q. (See <a class="local">'Using the POP-Q system'</a> below.)</p><p class="headingAnchor" id="H1121160"><span class="h2">Baden-Walker system</span><span class="headingEndMark"> — </span>While not recommended by leading societies, the Baden-Walker Halfway Scoring System is another commonly used POP staging system. The degree, or grade, of each prolapsed structure is described individually (eg, grade 1 anterior vaginal wall prolapse or grade 3 uterine prolapse). The grade/degree is defined as the extent of prolapse for each structure noted on examination while the patient is straining. Because there are no clear demarcations among the cut-off stages, the Baden-Walker system lacks the precision and reproducibility of the POP-Q system.</p><p>The system has five degrees/grades [<a href="#rid10">10</a>]. For the urethra, posterior descent is graded, for other anatomic sites, the lowest part is graded:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>0</strong> – Normal position for each respective site</p><p class="bulletIndent1"><span class="glyph">●</span><strong>1</strong> – Descent halfway to the hymen</p><p class="bulletIndent1"><span class="glyph">●</span><strong>2</strong> – Descent to the hymen</p><p class="bulletIndent1"><span class="glyph">●</span><strong>3</strong> – Descent halfway past the hymen</p><p class="bulletIndent1"><span class="glyph">●</span><strong>4</strong> – Maximum possible descent for each site</p><p></p><p>Modifications of this system also exist.</p><p>The Baden-Walker system lacks the precision and reproducibility of the POP-Q system.</p><p class="headingAnchor" id="H7156552"><span class="h1">SYMPTOM AND MEDICAL HISTORY</span><span class="headingEndMark"> — </span>The medical history includes symptoms specific to prolapse, as well as urinary, defecatory, and sexual problems, which are often associated with POP. A multidisciplinary working group has proposed use of a combined set of validated questionnaires, titled IMPACT, to assess patient-reported outcomes specific to pelvic floor disorders [<a href="#rid11">11</a>]. A detailed discussion of symptoms associated with POP can be found separately. (See  <a class="medical medical_review" href="/z/d/html/8072.html" rel="external">"Pelvic organ prolapse in females: Epidemiology, risk factors, clinical manifestations, and management", section on 'Clinical manifestations'</a>.)</p><p>No robust screening questionnaires for mild POP exist. Some epidemiologic studies have used a single question to screen for prolapse from a validated pelvic floor distress questionnaire [<a href="#rid12">12</a>], which likely captures only those patients with severe prolapse. By asking the question "Do you experience bulging or something falling out you can see or feel in the vaginal area?", the National Health and Nutrition Examination Survey reported a 3 percent prevalence rate of advanced prolapse in the study population of nearly 2500 women [<a href="#rid13">13</a>]. Women with a positive response to this question should undergo a pelvic examination.</p><p>Symptom assessment is important, since treatment is generally not indicated for asymptomatic POP. In addition, assessment of POP symptoms and their impact on a patient’s quality of life helps patients and clinicians set treatment goals [<a href="#rid14">14-16</a>]. Treatment of urinary or defecatory conditions is typically coordinated with POP treatment. (See  <a class="medical medical_review" href="/z/d/html/14212.html" rel="external">"Pelvic organ prolapse in women: Choosing a primary surgical procedure", section on 'Symptomatic prolapse'</a>.)</p><p>Current symptoms or history of conditions that may mimic (eg, pelvic mass, genital tract bleeding) or exacerbate (eg, etiologies of urinary or fecal incontinence other than POP) symptoms of POP should also be elicited. (See  <a class="medical medical_review" href="/z/d/html/8072.html" rel="external">"Pelvic organ prolapse in females: Epidemiology, risk factors, clinical manifestations, and management", section on 'Clinical manifestations'</a>.)</p><p>In addition, the medical history should include a review of medical comorbidities that could impact whether the patient is a candidate for surgical treatment. (See  <a class="medical medical_review" href="/z/d/html/4815.html" rel="external">"Overview of the principles of medical consultation and perioperative medicine"</a>.)</p><p class="headingAnchor" id="H22988189"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>POP is diagnosed with a pelvic examination using the POP quantification (POP-Q) system. A medical history is also important to elicit prolapse-associated symptoms, since treatment is generally indicated only for symptomatic prolapse. (See  <a class="medical medical_review" href="/z/d/html/14212.html" rel="external">"Pelvic organ prolapse in women: Choosing a primary surgical procedure", section on 'Symptomatic prolapse'</a>.)</p><p class="headingAnchor" id="H1120407"><span class="h1">APPROACH TO THE EXAMINATION</span></p><p class="headingAnchor" id="H1120534"><span class="h2">Examination components</span><span class="headingEndMark"> — </span>Physical examination of women with POP includes the following components:</p><p class="bulletIndent1"><span class="glyph">●</span>Visual inspection</p><p class="bulletIndent1"><span class="glyph">●</span>Speculum examination</p><p class="bulletIndent1"><span class="glyph">●</span>Bimanual pelvic examination</p><p class="bulletIndent1"><span class="glyph">●</span>Rectovaginal examination</p><p class="bulletIndent1"><span class="glyph">●</span>Neuromuscular examination</p><p></p><p>Each component of the examination is discussed in the sections below.</p><p class="headingAnchor" id="H2794653"><span class="h2">Equipment</span><span class="headingEndMark"> — </span>Instruments that are useful in assessment of pelvic prolapse include a Sims retractor (single blade speculum) or a bivalve speculum that can be easily taken apart so that the anterior and posterior blades can be used separately to observe individual compartments of the vagina (anterior, posterior, apical).</p><p>To make the measurements for the POP-Q system, a ruler or a large cotton swab or sponge forceps marked in 1 cm increments is used [<a href="#rid2">2,6</a>].</p><p class="headingAnchor" id="H1120391"><span class="h2">Patient positioning</span><span class="headingEndMark"> — </span>The examination is performed in both the dorsal lithotomy and standing positions with the patient relaxed and then straining (to demonstrate the maximum degree of prolapse) [<a href="#rid17">17</a>]. The extent of prolapse visualized on examination should confirm the patient's description of bulging symptoms. If the severity of prolapse visualized does not correlate with the patient's description, a handheld mirror may be beneficial to confirm that what the provider is seeing is the full extent of the prolapse. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dorsal lithotomy</strong> – The patient is examined initially in the dorsal lithotomy position. A prospective series of 218 women reported that performing the pelvic examination in the left lateral position (a common position used to assess pelvic support in the United Kingdom) yielded results that correlated highly with findings in the lithotomy position [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Standing</strong> – The examination is then repeated with the patient standing [<a href="#rid17">17,19</a>]. This is the position that will best approximate the extent of prolapse that the patient experiences daily. In the standing position, the patient places one foot on a well-supported footstool. The examining gown is lifted slightly to expose the genital area during the examination [<a href="#rid20">20</a>].</p><p></p><p>Additional techniques to help the patient reproduce the extent of prolapse can include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>In office</strong> – Patients who have difficulty generating a Valsalva maneuver in dorsal lithotomy or standing positions may be able to elicit the full extent of prolapse by sitting on the toilet and coughing and/or straining.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>At home</strong> – For patients who are unable to reproduce the bulge that they experience at home, a photograph of the prolapse at its full extent can be helpful. </p><p></p><p class="headingAnchor" id="H20651678"><span class="h2">Documentation</span><span class="headingEndMark"> — </span>A full description of the examination is recorded, including [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Type of examination table, speculum, and retractors</p><p class="bulletIndent1"><span class="glyph">●</span>Patient position</p><p class="bulletIndent1"><span class="glyph">●</span>Bladder and rectal fullness</p><p></p><p>It is important to note and document any episodes of urinary, fecal, or flatal incontinence that occur during the examination.</p><p>The findings of the examination should be recorded using a quantitative and reproducible method for recording POP. We use the POP-Q system, as noted above. (See <a class="local">'POP-Q system'</a> above.)</p><p class="headingAnchor" id="H1120399"><span class="h1">VISUAL INSPECTION</span><span class="headingEndMark"> — </span>The first part of the examination is a visual inspection of the vulvar, perineal, and perianal areas with the patient in the dorsal lithotomy position. As during other components of the examination, the inspection should be performed initially with the patient relaxed and then while straining. Findings that should be noted during this component of the examination include:</p><p class="bulletIndent1"><span class="glyph">●</span>Transverse diameter of the genital hiatus (eg, the space between the labia majora)</p><p class="bulletIndent1"><span class="glyph">●</span>Protrusion of the vaginal walls or cervix to or beyond the introitus (uterine procidentia)</p><p class="bulletIndent1"><span class="glyph">●</span>Length and condition of the perineum</p><p class="bulletIndent1"><span class="glyph">●</span>Rectal prolapse</p><p></p><p>In patients with prolapse to or beyond the hymen, the vaginal tissue is examined for ulceration.</p><p>Any other findings (eg, skin or mucosal lesions) should be noted and evaluated appropriately. (See  <a class="medical medical_review" href="/z/d/html/3253.html" rel="external">"The gynecologic history and pelvic examination", section on 'External genitalia'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">SPECULUM AND BIMANUAL EXAMINATION</span><span class="headingEndMark"> — </span>The speculum and bimanual examinations are the principal components used to evaluate POP. The patient is examined in the dorsal lithotomy and then standing positions, while relaxed and then straining, as noted above. (See <a class="local">'Patient positioning'</a> above.)</p><p>Prolapse of each anatomic compartment is evaluated as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Apical prolapse (prolapse of the cervix or vaginal vault)</strong> – A bivalve speculum is inserted into the vagina and then slowly withdrawn; any descent of the apex is noted.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anterior vaginal wall</strong> – A Sims retractor or the posterior blade of a bivalve speculum is inserted into the vagina with gentle pressure on the posterior vaginal wall to isolate visualization of the anterior vaginal wall.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Posterior vaginal wall</strong> – A Sims retractor or the posterior blade of a bivalve speculum into the vagina with gentle pressure on the anterior vaginal wall to isolate visualization of the posterior vaginal wall. If the posterior blade of a bivalve speculum is used, the device is rotated 180 degrees and used to elevate the anterior vaginal wall.</p><p></p><p>The terms anterior vaginal wall prolapse, posterior vaginal wall prolapse and apical prolapse are preferred to the terms "cystocele," "rectocele," and "enterocele" because vaginal topography does not reliably predict the location of the associated viscera in women with POP. (See  <a class="medical medical_review" href="/z/d/html/8072.html" rel="external">"Pelvic organ prolapse in females: Epidemiology, risk factors, clinical manifestations, and management", section on 'Terminology'</a>.)</p><p>To complete the examination, a bimanual examination is performed in order to evaluate for any coexisting pelvic abnormalities. (See  <a class="medical medical_review" href="/z/d/html/3253.html" rel="external">"The gynecologic history and pelvic examination", section on 'Bimanual examination'</a>.)</p><p class="headingAnchor" id="H20651075"><span class="h2">Using the POP-Q system</span><span class="headingEndMark"> — </span>In the POP-Q system, the topography of the vagina is described using six points (two on the anterior vaginal wall, two on the superior vagina, and two on the posterior vaginal wall) and several other measurements  (<a class="graphic graphic_figure graphicRef74368" href="/z/d/graphic/74368.html" rel="external">figure 1</a>) [<a href="#rid2">2</a>]. Taken together, these measurements can be used to produce a sagittal diagram of the prolapse.</p><p>During the examination, the maximum extent of prolapse is determined for each of the six points. Maximal prolapse is defined by the following findings:</p><p class="bulletIndent1"><span class="glyph">●</span>Vaginal wall becomes tight during straining</p><p class="bulletIndent1"><span class="glyph">●</span>Traction on the prolapse causes no further descent</p><p class="bulletIndent1"><span class="glyph">●</span>Patient confirms that protrusion is maximal</p><p></p><p>The maximal point of prolapse of each of the six points is then recorded in relation to a fixed point of reference, the anterior-posterior plane of the hymen.</p><p>All measurements are expressed in centimeters; increments of 0.5 cm can also be used, if clinically useful. A minus sign is used to designate a point that is proximal, or superior, to the hymenal plane (eg, -3 cm), while points distal or inferior to the hymenal plane are preceded by a positive sign (eg, +2 cm).</p><p>The measurements can be marked on line diagrams  (<a class="graphic graphic_figure graphicRef62226" href="/z/d/graphic/62226.html" rel="external">figure 3</a>), noted on a grid  (<a class="graphic graphic_figure graphicRef57450" href="/z/d/graphic/57450.html" rel="external">figure 2</a>), or recorded in text form.</p><p class="headingAnchor" id="H20651194"><span class="h3">POP-Q measurements</span><span class="headingEndMark"> — </span>Each point is located by measuring along the vaginal wall or identifying the most dependent point of a prolapsed structure. The measurement is then taken of the distance from the point to the hymenal plane. The anterior and posterior vaginal measurements are independent of each other (they do not need to match). The anatomic location of each point is  (<a class="graphic graphic_figure graphicRef74368" href="/z/d/graphic/74368.html" rel="external">figure 1</a>) [<a href="#rid21">21,22</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Anterior vaginal wall points:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Point <strong>Aa</strong> is located in the midline of the anterior vaginal wall, 3 cm proximal to the external urethral meatus, corresponding approximately to the urethrovesical junction. The quantitative value of point Aa is anywhere from -3 to +3 cm from the hymenal plane, depending upon the extent of anterior wall prolapse.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Point <strong>Ba</strong> is the most distal (ie, most dependent) position of any part of the anterior vaginal wall between point Aa and the vaginal cuff or anterior vaginal fornix. If there is no prolapse, point Ba is -3 cm by definition. In a woman with total posthysterectomy vault prolapse, Ba has a positive value equal to the distance between the vaginal apex and hymenal plane (so the quantitative value of point Ba can range from the most supported measurement [-3], to the most prolapse portion beyond the hymenal ring [this may exceed +3 cm]).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Superior vagina points:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Point <strong>C</strong> is the most distal (ie, most dependent) edge of the cervix or the leading edge of the vaginal cuff (posthysterectomy).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Point <strong>D</strong> is measured only in women with a cervix. It is the deepest point of the posterior fornix, corresponding approximately to where the uterosacral ligaments attach to the posterior cervix. Measuring this point distinguishes between suspensory failure of the uterosacral-cardinal ligament complex and cervical elongation: if point C is significantly more positive than point D (&gt;4 cm), the cervix is elongated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Posterior vaginal wall points (these are analogous to the two points on the anterior wall):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Point <strong>Ap</strong> is located in the midline of the posterior vaginal wall, 3 cm proximal to the posterior hymen. The quantitative value of point Ap is anywhere from -3 to +3 cm from the hymenal plane, depending upon the extent of posterior wall prolapse.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Point <strong>Bp</strong> is the most distal (ie, most dependent) position of any part of the upper posterior vaginal wall between point Ap and the vaginal cuff or posterior vaginal fornix. If there is no prolapse, point Bp is -3 cm by definition. In a woman with total posthysterectomy vaginal prolapse, Bp has a positive value equal to the distance between the vaginal apex and hymenal plane (so the quantitative value of point Bp can range from the most supported measurement [-3], to the most prolapse portion beyond the hymenal ring [this may exceed +3 cm]).</p><p></p><p>In addition, the total vaginal length (<strong>TVL</strong>) is measured by reducing point C or D to its most superior position (eg, with a swab or ring forceps).</p><p>Finally, two additional measurements give a frontal (coronal) view of the prolapse from the perspective of an examination in the lithotomy position. These measurements complement the points determined in the sagittal view:</p><p class="bulletIndent1"><span class="glyph">●</span>The genital hiatus (<strong>gh</strong>) is measured anterior-posteriorly from the middle of the external urethral meatus to the posterior midline hymen. If the location of the hymen is obscured by a band of skin (usually from surgery or episiotomy repair), the firm tissue of the perineal body is the posterior margin of this measurement.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The perineal body (<strong>pb</strong>) is measured from the posterior margin of the genital hiatus to the midanal opening.</p><p></p><p class="headingAnchor" id="H20651483"><span class="h3">POP-Q staging</span><span class="headingEndMark"> — </span>The POP-Q system provides a detailed description of vaginal anatomy. For the purposes of simple clinical communication or grouping patients for research purposes, an ordinal staging system using the POP-Q measurements was developed.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage 0</strong> – No prolapse. Points Aa, Ap, Ba, and Bp are all -3 cm and point D (if uterus is present) or C (posthysterectomy) equals or nearly equals TVL (-TVL cm to -[TVL-2] cm).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage I</strong> – The requirements for stage 0 are not met, but the most distal portion of the prolapse is &gt;1 cm proximal to the level of the hymenal plane (ie, quantitation value &lt;-1 cm).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage II</strong> – The most distal portion of the prolapse is between ≤1 cm proximal to the hymenal plane and ≤1 cm distal to the hymenal plane (ie, quantitation value ≥-1 cm to ≤+1 cm).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage III</strong> – The most distal portion of the prolapse is between &gt;1 cm distal to the hymenal plane, but no further than 2 cm less than the total vaginal length in centimeters (quantitative value &gt;+1 cm but &lt;+[TVL-2] cm). In other words, the maximum prolapse is more than 1 cm outside the hymenal plane, but it is 2 cm less than the maximum possible protrusion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage IV</strong> – Eversion of the total length of the vagina. The protrusion extends to or beyond (TVL-2) cm (quantitative value ≥+[TVL-2] cm).</p><p></p><p>It may be helpful to designate the leading edge of prolapse, such as stage 2 prolapse with the anterior compartment leading.</p><p class="headingAnchor" id="H9800359"><span class="h3">Modifications of the POP-Q system and reporting POP-Q results</span></p><p class="headingAnchor" id="H9800329"><span class="h4">Simplified POP-Q</span><span class="headingEndMark"> — </span>A simplified version of the POP-Q system, which was developed by an international group of investigators, has been proposed [<a href="#rid9">9,23</a>]. Like the standard POP-Q examination, the Simple POP-Q (S-POP-Q) measures the anterior, posterior and up to two measurements of the apex, including both the cervix, in women who still have one, and posterior cul-de-sac. The S-POP-Q records the ordinal stage of the four measurements by estimating the distances involved. For measurement of the anterior wall, a point approximately 3 cm or halfway up the anterior vaginal wall is visualized, the woman is asked to strain, and the amount of descent is recorded. A similar process is carried out to estimate the descent of the posterior wall. Finally, a Sims speculum is utilized to record the descent of the apex of the vagina. The following definitions are used to Stage the prolapse:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage 1</strong> – Prolapse where the given point remains at least 1 cm above the hymenal remnants.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage 2</strong> – Prolapse where the given point descends to the introitus, defined as an area extending from 1 cm above to 1 cm below the hymenal remnants.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage 3</strong> – Prolapse where the given point descends greater than 1 cm past the hymenal remnants, but does not represent complete vaginal vault eversion or complete uterine procidentia. This implies that at least some portion of the vaginal mucosa is not everted.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stage 4</strong> – Complete vaginal vault eversion or complete uterine procidentia. This implies that the vagina and/or uterus are maximally prolapsed with essentially the entire extent of the vaginal mucosa everted.</p><p></p><p>The S-POP-Q has been validated against the original staging system of the POP-Q and has been found to be highly correlated [<a href="#rid9">9,23</a>].</p><p class="headingAnchor" id="H9800345"><span class="h4">SLmax</span><span class="headingEndMark"> — </span>SL<sub>max</sub>, also known as maximum vaginal descent, was introduced as a continuous value of vaginal support that describes prolapse as a single summary score. This measure is calculated as a single score for comparison of prolapse between populations and is not meant to replace the more detailed POP-Q. SL<sub>max</sub> simply represents the most distal presenting part of the vagina, in centimeters. The minimum value is -3 by definition, and the measure was shown to correlate well with POP-Q measurements and results of the Pelvic Organ Prolapse Distress Inventory [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Additional examination techniques</span></p><p class="headingAnchor" id="H5"><span class="h3">Simulated apical support</span><span class="headingEndMark"> — </span>Repeating the speculum examination with simulated apical support (ie, supporting the vaginal apex with a large cotton swab or ring forceps) approximates the results following apical prolapse repair. Reduction of apical prolapse temporarily corrects anterior and posterior vaginal wall prolapse in many women [<a href="#rid25">25</a>]. This examination technique may help a clinician decide whether a vaginal pessary may be helpful or, in preoperative patients, whether to perform apical prolapse relapse repair. (See  <a class="medical medical_review" href="/z/d/html/8081.html" rel="external">"Vaginal pessaries: Indications, devices, and approach to selection"</a> and  <a class="medical medical_review" href="/z/d/html/14212.html" rel="external">"Pelvic organ prolapse in women: Choosing a primary surgical procedure", section on 'Concomitant repair of apical and anterior or posterior prolapse'</a>.)</p><p class="headingAnchor" id="H7"><span class="h3">Inspection for paravaginal defects</span><span class="headingEndMark"> — </span>Evaluation for paravaginal defects is not part of the POP-Q system because the clinical significance of paravaginal defects is unclear. Paravaginal defects occur when the anterior vaginal wall detaches from its lateral support, the arcus tendineus. The arcus tendineus is a line of connective tissue that runs from posterior (ischial spine) to anterior (symphysis pubis) anteriorly  (<a class="graphic graphic_figure graphicRef51329" href="/z/d/graphic/51329.html" rel="external">figure 4</a>). Surgical repair of paravaginal defects is not typically performed as it does not improve surgical outcomes. (See  <a class="medical medical_review" href="/z/d/html/8084.html" rel="external">"Pelvic organ prolapse in women: Surgical repair of anterior vaginal wall prolapse"</a> and  <a class="medical medical_review" href="/z/d/html/8084.html" rel="external">"Pelvic organ prolapse in women: Surgical repair of anterior vaginal wall prolapse", section on 'Paravaginal defect repair'</a>.)</p><p class="headingAnchor" id="H1121338"><span class="h1">RECTOVAGINAL EXAMINATION</span><span class="headingEndMark"> — </span>A rectovaginal examination is performed to:</p><p class="bulletIndent1"><span class="glyph">●</span>Diagnose an enterocele</p><p class="bulletIndent1"><span class="glyph">●</span>Differentiate between a high rectocele and an enterocele</p><p class="bulletIndent1"><span class="glyph">●</span>Assess the integrity of the perineal body</p><p class="bulletIndent1"><span class="glyph">●</span>Detect rectal prolapse</p><p></p><p>The best method for detecting an enterocele is to perform the rectovaginal examination with the patient standing; the small bowel can be palpated in the cul-de-sac between thumb and forefinger  (<a class="graphic graphic_figure graphicRef76450" href="/z/d/graphic/76450.html" rel="external">figure 5</a>). (See  <a class="medical medical_review" href="/z/d/html/8076.html" rel="external">"Posterior vaginal defects (eg, rectocele): Clinical manifestations, diagnosis, and nonsurgical management"</a>.)</p><p class="headingAnchor" id="H1121527"><span class="h1">NEUROMUSCULAR EXAMINATION</span></p><p class="headingAnchor" id="H7155323"><span class="h2">Neurologic evaluation</span><span class="headingEndMark"> — </span>Gross neurologic assessment of the vulva and perineum is performed to screen for neurologic disease, although there is a low detection rate in the absence of gross neurologic symptoms or a prior diagnosis of a neurologic disorder.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medical and neurologic history</strong> – Detailed neurologic evaluation begins with a thorough medical history, including a personal or family history of neurologic disease or related conditions. Any abnormalities of speech or gross motor function should be noted while taking the medical history.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sensation</strong> – Sensory of the lumbosacral dermatomes for light touch and sharp touch is performed using a small cotton swab and a sharp point [<a href="#rid26">26</a>]. If sensory function is abnormal, more detailed neurologic testing may be warranted.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sacral reflexes</strong> – Sacral reflexes should also be assessed. To evaluate for sacral nerve integrity, the bulbocavernosus reflex is elicited by gently tapping or squeezing the clitoris. The anocutaneous reflex (anal wink sign) is triggered by stroking the skin immediately surrounding the anus and observing a reflexive contraction of the external anal sphincter; this reflex should be elicited bilaterally. Absence of these reflexes is not always abnormal and hyperreflexia or asymmetry may in fact be more suggestive of a neurologic etiology. As with sensory function, abnormal findings of reflex testing warrant a more detailed neurologic examination and possible referral to a specialist.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Motor function</strong> – Sacral nerve route motor function is further evaluated by having the patient move the lower extremity; this includes active extension and flexion of the knee, ankle, and toes. Strength is assessed by having the patient move each joint against resistance. The patellar and plantar reflexes are also assessed.</p><p></p><p>If abnormal findings are encountered, the patient should be referred to a neurologist.</p><p class="headingAnchor" id="H20651633"><span class="h2">Pelvic floor muscle testing</span><span class="headingEndMark"> — </span>The pelvic floor musculature is inspected to evaluate integrity and symmetry. The examiner should also note the presence of scarring and whether pelvic floor contraction pulls the perineum inward. Palpation through the vagina or rectum helps in assessing pelvic floor squeeze strength and levator muscle thickness. The tone and strength of the pelvic floor muscles can be assessed by asking the patient to contract the pelvic floor muscles around the examining fingers. Women with poor pelvic floor muscle function may benefit from pelvic physical therapy.</p><p>Guidelines have been published by the International Continence Society to assess pelvic floor musculature tone [<a href="#rid27">27</a>]. Four conditions have been defined: normal pelvic floor muscles are those which can voluntarily contract and relax, overactive pelvic floor muscles are muscles which do not relax, underactive pelvic floor muscles are those which cannot voluntarily contract, and nonfunctioning pelvic floor muscles is when there is no pelvic floor muscle action palpable [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/z/d/html/8072.html" rel="external">"Pelvic organ prolapse in females: Epidemiology, risk factors, clinical manifestations, and management", section on 'Pelvic floor muscle exercises'</a>.)</p><p>Instrumental muscle testing is available, but none of these techniques has proven clinical applicability in the assessment of POP. Electromyography with needle electrodes permits visualization of individual motor unit action potentials; surface electrodes detect activity of groups of motor units. Pressure recording from the urethra, vagina, and anus can be used to assess pelvic floor muscle strength. </p><p class="headingAnchor" id="H7155687"><span class="h1">ANCILLARY STUDIES</span><span class="headingEndMark"> — </span>Ancillary diagnostic procedures are performed mainly for evaluation of bladder or bowel function. Additional testing is occasionally used to further evaluate prolapse itself [<a href="#rid29">29</a>]. Infrequently, women will present with complaints of prolapse, yet on examination have evidence of excellent vaginal support as measured by the POP-Q. It is possible that these women have descent of the perineum or that they have an enterocele that descends between the vaginal and rectum or bladder and rectum without displacing the anterior or posterior vaginal walls.</p><p>Whether to proceed with ancillary testing depends upon the presenting symptoms and whether there are symptoms that do not correlate with physical examination findings (eg, bladder or bowel symptoms are present in the absence of prolapse).</p><p class="headingAnchor" id="H7156175"><span class="h2">Evaluation of prolapse</span></p><p class="headingAnchor" id="H7156232"><span class="h3">Photography</span><span class="headingEndMark"> — </span>If prolapse is stage II or greater, photographs that include a centimeter tape as a frame of reference can help objectively document presurgical findings or serial changes in an individual patient.</p><p class="headingAnchor" id="H7155694"><span class="h3">Imaging</span><span class="headingEndMark"> — </span>There are few clinical uses of imaging to evaluate the anatomic findings of prolapse. Imaging techniques are used for some aspects of evaluation of urinary or bowel function. (See  <a class="medical medical_review" href="/z/d/html/6874.html" rel="external">"Female urinary incontinence: Evaluation", section on 'Evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/8072.html" rel="external">"Pelvic organ prolapse in females: Epidemiology, risk factors, clinical manifestations, and management", section on 'Diagnosis and classification'</a>.)</p><p>Dynamic magnetic resonance imaging (dMRI) is under investigation for use in identifying site-specific pelvic support defects, as well as differentiating between a rectocele and an enterocele [<a href="#rid30">30</a>]. However, there are no standardized criteria for use of this modality for the diagnosis of POP, and it is largely used for research purposes [<a href="#rid31">31</a>]. A retrospective study compared dMRI defecography phase findings with physical examination grading of POP using the Baden-Walker system. The defecography phase of the dMRI correlated well with the Baden-Walker evaluation for anatomically significant prolapse in both the anterior and posterior compartments; however, the dMRI was superior to physical examination for enterocele detection and was better able to distinguish an enterocele from a rectocele [<a href="#rid32">32</a>]. Therefore, the dMRI may have the greatest diagnostic value in patients with apical and posterior compartment defects where the presence of an enterocele is suspected but not certain on physical examination. dMRI may also be a useful diagnostic tool when patients' symptoms are in excess of their physical examination findings.</p><p class="headingAnchor" id="H90744232"><span class="h4">Perineal ultrasound</span><span class="headingEndMark"> — </span>Ultrasound of the perineum can identify levator ani defects as well as prolapse of the bladder, rectum, and/or intestines into the vagina. The ability to diagnose levator ani evulsion from the symphysis pubis after childbirth or other perineal trauma is emerging as an important predictor of both the development of prolapse as well as the success and failure of prolapse repairs [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H7155701"><span class="h2">Urinary tract evaluation</span><span class="headingEndMark"> — </span>Urinary tract evaluation for women with prolapse is guided by an individual patient’s complaints (eg, incontinence, urinary retention). Studies may include testing for urinary tract infection, urinary incontinence, or urinary retention.</p><p>This section will briefly discuss major components of urinary tract evaluation in women with POP. A detailed discussion of the evaluation of women with urinary incontinence, overactive bladder syndrome, or obstructive urinary symptoms can be found separately. (See  <a class="medical medical_review" href="/z/d/html/6874.html" rel="external">"Female urinary incontinence: Evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/8088.html" rel="external">"Surgical management of stress urinary incontinence in females: Preoperative evaluation for a primary procedure"</a> and  <a class="medical medical_review" href="/z/d/html/8069.html" rel="external">"Urodynamic evaluation of women with incontinence"</a>.)</p><p class="headingAnchor" id="H7155809"><span class="h3">Urinary incontinence</span><span class="headingEndMark"> — </span>Urinary incontinence often coexists with POP. While women with POP often have stress urinary incontinence (SUI) symptoms, many women with stage II or higher apical prolapse remain continent despite loss of anterior vaginal and bladder/urethral support. However, 13 to 65 percent of continent women develop symptoms of SUI after surgical correction of the prolapse [<a href="#rid34">34-37</a>]. This likely occurs because the prolapse kinks and obstructs the urethra; this obstruction is alleviated when the prolapse is repaired. This is referred to as "occult" or "potential" stress incontinence.</p><p>All continent women with apical prolapse should have a preoperative evaluation for occult SUI by reducing the prolapse and observing whether or not the patient leaks with cough or Valsalva. However, preoperative prolapse reduction testing does not accurately predict postoperative stress incontinence (approximately 40 percent of women with negative testing will develop postoperative stress incontinence) [<a href="#rid38">38</a>]. The routine use of urodynamics in women with prolapse, with or without symptomatic SUI, is controversial. Urodynamic testing is time-consuming and incurs expense, and it is unclear whether it improves surgical decision-making in women with uncomplicated SUI. We suggest urodynamics be performed only in women with complicated SUI (eg, previous anti-incontinence surgery, neurogenic lower urinary tract dysfunction, or suspicion of a nonstress etiology of urinary incontinence) or when symptoms are not consistent with physical examination findings. The approach to women with prolapse and urinary incontinence is presented in detail separately.</p><p>Women with prolapse also commonly have urgency urinary incontinence (UUI) symptoms. Whether or not these symptoms resolve with surgical correction of the prolapse is controversial, although most providers feel that prolapse reduction is an important component of UUI treatment in women with advanced POP.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/8068.html" rel="external">"Pelvic organ prolapse and stress urinary incontinence in females: Surgical treatment", section on 'Occult SUI'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/8068.html" rel="external">"Pelvic organ prolapse and stress urinary incontinence in females: Surgical treatment", section on 'Approach based on patient presentation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/8088.html" rel="external">"Surgical management of stress urinary incontinence in females: Preoperative evaluation for a primary procedure", section on 'Urodynamic testing'</a>.)</p><p></p><p class="headingAnchor" id="H7155816"><span class="h3">Urinary retention</span><span class="headingEndMark"> — </span>A postvoid residual (PVR) urine volume is one method used to evaluate for urinary retention. Voiding trials to assess PVR can be either retrograde or spontaneous. At least one study has reported that ultrasound assessment of PVR may be less reliable in patients with more advanced prolapse [<a href="#rid39">39</a>]. There is no clear consensus on what is a normal or abnormal PVR urine volume. In general, a PVR of greater than 100 cc can be suggestive of voiding dysfunction or detrusor weakness; the range of normal values for PVR and treatment options remains controversial [<a href="#rid40">40-42</a>]. After prolapse repair, the majority of women with preoperative urinary retention have improved PVRs [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/z/d/html/17173.html" rel="external">"Postoperative urinary retention in females", section on 'Voiding trials'</a>.)</p><p class="headingAnchor" id="H7155823"><span class="h2">Bowel function evaluation</span><span class="headingEndMark"> — </span>Women who are undergoing evaluation for POP may also require further evaluation of anal incontinence or obstructive symptoms (eg, constipation, incomplete emptying). Defecography may demonstrate an enterocele that was not detected on POP-Q. A detailed discussion of the evaluation of these conditions can be found separately. (See  <a class="medical medical_review" href="/z/d/html/2561.html" rel="external">"Fecal incontinence in adults: Etiology and evaluation", section on 'Evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/2637.html" rel="external">"Etiology and evaluation of chronic constipation in adults", section on 'Evaluation'</a>.)</p><p class="headingAnchor" id="H7156303"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>In women with symptoms of a vaginal bulge or pelvic pressure, a pelvic mass should be excluded with pelvic examination, and if appropriate, imaging studies. Common conditions that may present with these symptoms include adnexal (eg, benign ovarian cysts or ovarian cancer) and uterine masses (eg, fibroids). Women with genital tract bleeding should also undergo appropriate evaluation to identify the source of bleeding and exclude malignancy. (See  <a class="medical medical_review" href="/z/d/html/5486.html" rel="external">"Uterine fibroids (leiomyomas): Epidemiology, clinical features, diagnosis, and natural history", section on 'Diagnostic evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/5440.html" rel="external">"Causes of female genital tract bleeding"</a> and  <a class="medical medical_review" href="/z/d/html/83704.html" rel="external">"Approach to the patient with an adnexal mass", section on 'Clinical presentation'</a>.)</p><p>Urinary (incontinence, retention, overactive bladder syndrome) or bowel (incontinence, obstructive symptoms) conditions are often associated with POP, as noted above (see  <a class="medical medical_review" href="/z/d/html/8072.html" rel="external">"Pelvic organ prolapse in females: Epidemiology, risk factors, clinical manifestations, and management", section on 'Clinical manifestations'</a>). While these symptoms are suggestive of POP, pelvic examination may reveal the presence of one or more of these conditions without significant prolapse. Regardless of the presence or absence of POP, women with these symptoms should undergo thorough evaluation to determine whether they are caused or exacerbated by medical conditions other than POP. (See  <a class="medical medical_review" href="/z/d/html/2561.html" rel="external">"Fecal incontinence in adults: Etiology and evaluation", section on 'Evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/2637.html" rel="external">"Etiology and evaluation of chronic constipation in adults", section on 'Evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/6874.html" rel="external">"Female urinary incontinence: Evaluation", section on 'Evaluation'</a>.)</p><p class="headingAnchor" id="H1499229624"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/122273.html" rel="external">"Society guideline links: Pelvic organ prolapse"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/122885.html" rel="external">"Society guideline links: Gynecologic surgery"</a>.)</p><p class="headingAnchor" id="H20"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Pelvic organ prolapse (POP) is herniation of the pelvic organs to or beyond the vaginal walls. A medical history is important to elicit prolapse-associated symptoms, since treatment is generally indicated only for symptomatic prolapse. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medical history</strong> – The medical history includes symptoms specific to prolapse, as well as urinary, defecatory, and sexual complaints, which are often associated with POP. Conditions that mimic prolapse (eg, pelvic mass) or comorbidities that may impact surgical treatment are assessed during the medical history. (See <a class="local">'Symptom and medical history'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – POP is diagnosed during pelvic examination using the Pelvic Organ Prolapse Quantitation (POP-Q) system. POP-Q is an objective, site-specific system for describing  (<a class="graphic graphic_figure graphicRef57450" href="/z/d/graphic/57450.html" rel="external">figure 2</a>), staging  (<a class="graphic graphic_table graphicRef72477" href="/z/d/graphic/72477.html" rel="external">table 1</a>), and communicating the sites and degree of POP  (<a class="graphic graphic_figure graphicRef62226" href="/z/d/graphic/62226.html" rel="external">figure 3</a>). While other classification systems exist, these are less precise and difficult to reproduce and communicate. (See <a class="local">'Classification of pelvic organ prolapse'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>POP-Q</strong> – Each point is located by measuring along the vaginal wall or identifying the most dependent point of a prolapsed structure. The measurement is then taken of the distance from the point to the hymenal plane. The anterior and posterior vaginal measurements are independent of each other (they do not need to match). (See <a class="local">'Using the POP-Q system'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Rectovaginal exam</strong> – A rectovaginal examination is performed to diagnose an enterocele and differentiate between a high rectocele and an enterocele. (See <a class="local">'Rectovaginal examination'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neuromuscular examination</strong> – Gross neurologic assessment is performed to screen for neurologic disease. Assessment includes a history, testing of sensation, sacral reflexes, motor function, and pelvic floor muscle strength. (See <a class="local">'Neuromuscular examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Additional tests</strong> – Ancillary diagnostic procedures are performed mainly for evaluation of bladder or bowel function, although additional testing is occasionally used to further evaluate prolapse itself. (See <a class="local">'Ancillary studies'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Maher C, Feiner B, Baessler K, Schmid C. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2013; :CD004014.</a></li><li><a class="nounderline abstract_t">Bump RC, Mattiasson A, Bø K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996; 175:10.</a></li><li><a class="nounderline abstract_t">Brubaker L, Norton P. Current clinical nomenclature for description of pelvic organ prolapse. J Pelvic Surg 1996; 2:257.</a></li><li><a class="nounderline abstract_t">Practice Bulletin No. 176: Pelvic Organ Prolapse. Obstet Gynecol 2017; 129:e56.</a></li><li><a class="nounderline abstract_t">Hall AF, Theofrastous JP, Cundiff GW, et al. Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system. Am J Obstet Gynecol 1996; 175:1467.</a></li><li><a class="nounderline abstract_t">Muir TW, Stepp KJ, Barber MD. Adoption of the pelvic organ prolapse quantification system in peer-reviewed literature. Am J Obstet Gynecol 2003; 189:1632.</a></li><li><a class="nounderline abstract_t">Treszezamsky AD, Rascoff L, Shahryarinejad A, Vardy MD. Use of pelvic organ prolapse staging systems in published articles of selected specialized journals. Int Urogynecol J 2010; 21:359.</a></li><li><a class="nounderline abstract_t">Vierhout ME, Stoutjesdijk J, Spruijt J. A comparison of preoperative and intraoperative evaluation of patients undergoing pelvic reconstructive surgery for pelvic organ prolapse using the Pelvic Organ Prolapse Quantification System. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17:46.</a></li><li><a class="nounderline abstract_t">Manonai J, Mouritsen L, Palma P, et al. The inter-system association between the simplified pelvic organ prolapse quantification system (S-POP) and the standard pelvic organ prolapse quantification system (POPQ) in describing pelvic organ prolapse. Int Urogynecol J 2011; 22:347.</a></li><li><a class="nounderline abstract_t">ACOG Committee on Practice Bulletins--Gynecology. ACOG Practice Bulletin No. 85: Pelvic organ prolapse. Obstet Gynecol 2007; 110:717.</a></li><li><a class="nounderline abstract_t">Bordeianou LG, Anger JT, Boutros M, et al. Measuring Pelvic Floor Disorder Symptoms Using Patient-Reported Instruments: Proceedings of the Consensus Meeting of the Pelvic Floor Consortium of the American Society of Colon and Rectal Surgeons, the International Continence Society, the American Urogynecologic Society, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction. Female Pelvic Med Reconstr Surg 2020; 26:1.</a></li><li><a class="nounderline abstract_t">Barber MD, Kuchibhatla MN, Pieper CF, Bump RC. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 2001; 185:1388.</a></li><li><a class="nounderline abstract_t">Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008; 300:1311.</a></li><li><a class="nounderline abstract_t">Elkadry EA, Kenton KS, FitzGerald MP, et al. Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol 2003; 189:1551.</a></li><li><a class="nounderline abstract_t">Hullfish KL, Bovbjerg VE, Steers WD. Patient-centered goals for pelvic floor dysfunction surgery: long-term follow-up. Am J Obstet Gynecol 2004; 191:201.</a></li><li><a class="nounderline abstract_t">Mahajan ST, Elkadry EA, Kenton KS, et al. Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Am J Obstet Gynecol 2006; 194:722.</a></li><li><a class="nounderline abstract_t">Barber MD, Lambers A, Visco AG, Bump RC. Effect of patient position on clinical evaluation of pelvic organ prolapse. Obstet Gynecol 2000; 96:18.</a></li><li><a class="nounderline abstract_t">Digesu GA, Athanasiou S, Cardozo L, et al. Validation of the pelvic organ prolapse quantification (POP-Q) system in left lateral position. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:979.</a></li><li><a class="nounderline abstract_t">Visco AG, Wei JT, McClure LA, et al. Effects of examination technique modifications on pelvic organ prolapse quantification (POP-Q) results. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:136.</a></li><li><a class="nounderline abstract_t">Shull BL. Clinical evaluation of women with pelvic support defects. Clin Obstet Gynecol 1993; 36:939.</a></li><li><a class="nounderline abstract_t">Kenton K, Shott S, Brubaker L. Vaginal topography does not correlate well with visceral position in women with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 1997; 8:336.</a></li><li class="breakAll">Walters, MD. Description and classification of lower urinary tract dysfunction and pelvic organ prolapse. In: Urogynecology and Reconstructive Pelvic Surgery, 3rd ed, Walters, MD, Karram MM (Eds), Mosby Elsevier, Philadelphia 2007. p.58.</li><li><a class="nounderline abstract_t">Parekh M, Swift S, Lemos N, et al. Multicenter inter-examiner agreement trial for the validation of simplified POPQ system. Int Urogynecol J 2011; 22:645.</a></li><li><a class="nounderline abstract_t">Brubaker L, Barber MD, Nygaard I, et al. Quantification of vaginal support: are continuous summary scores better than POPQ stage? Am J Obstet Gynecol 2010; 203:512.e1.</a></li><li><a class="nounderline abstract_t">Lowder JL, Park AJ, Ellison R, et al. The role of apical vaginal support in the appearance of anterior and posterior vaginal prolapse. Obstet Gynecol 2008; 111:152.</a></li><li class="breakAll">Walters, MD. Evaluation of urinary Incontinence and Pelvic Organ Prolapse. In: Urogynecology and Reconstructive Surgery, 3rd, Walters, MD, Karram, MM (Eds), Mosby Elsevier, Phildelphia 2007. p.69.</li><li class="breakAll">www.icsoffice.org/ASPNET_membership/membership/documents/documents.aspx. (Accessed on January 16, 2012).</li><li><a class="nounderline abstract_t">Bo K, Frawley HC, Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J 2017; 28:191.</a></li><li class="breakAll">Flynn, MK, Amundsen, CL. Diagnosis of pelvic organ prolapse. In: Multidisiplinary management of female pelvic floor disorders, Chapple, CR, Zimmerman, PE (Eds), Churchill Livingstone, Philadelphia 2006. p. 120.</li><li><a class="nounderline abstract_t">Gupta S, Sharma JB, Hari S, et al. Study of dynamic magnetic resonance imaging in diagnosis of pelvic organ prolapse. Arch Gynecol Obstet 2012; 286:953.</a></li><li><a class="nounderline abstract_t">Broekhuis SR, Fütterer JJ, Barentsz JO, et al. A systematic review of clinical studies on dynamic magnetic resonance imaging of pelvic organ prolapse: the use of reference lines and anatomical landmarks. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:721.</a></li><li><a class="nounderline abstract_t">Lin FC, Funk JT, Tiwari HA, et al. Dynamic Pelvic Magnetic Resonance Imaging Evaluation of Pelvic Organ Prolapse Compared to Physical Examination Findings. Urology 2018; 119:49.</a></li><li><a class="nounderline abstract_t">Dietz HP. Ultrasound in the assessment of pelvic organ prolapse. Best Pract Res Clin Obstet Gynaecol 2019; 54:12.</a></li><li><a class="nounderline abstract_t">Ellerkmann RM, Cundiff GW, Melick CF, et al. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol 2001; 185:1332.</a></li><li><a class="nounderline abstract_t">Gutman RE, Ford DE, Quiroz LH, et al. Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms? Am J Obstet Gynecol 2008; 199:683.e1.</a></li><li><a class="nounderline abstract_t">Swift S, Woodman P, O'Boyle A, et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 2005; 192:795.</a></li><li><a class="nounderline abstract_t">Mouritsen L, Larsen JP. Symptoms, bother and POPQ in women referred with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:122.</a></li><li><a class="nounderline abstract_t">Visco AG, Brubaker L, Nygaard I, et al. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:607.</a></li><li><a class="nounderline abstract_t">Song XC, Yu X, Luo M, et al. Clinical Characteristics and Postoperative Symptoms of 85 Adolescents with Endometriosis. J Pediatr Adolesc Gynecol 2020; 33:519.</a></li><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists. Urinary incontinence in women. Obstet Gynecol 2005; 105:1533.</a></li><li><a class="nounderline abstract_t">Kleeman S, Goldwasser S, Vassallo B, Karram M. Predicting postoperative voiding efficiency after operation for incontinence and prolapse. Am J Obstet Gynecol 2002; 187:49.</a></li><li><a class="nounderline abstract_t">Foster RT Sr, Borawski KM, South MM, et al. A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing after transvaginal surgery. Am J Obstet Gynecol 2007; 197:627.e1.</a></li><li><a class="nounderline abstract_t">Fitzgerald MP, Kulkarni N, Fenner D. Postoperative resolution of urinary retention in patients with advanced pelvic organ prolapse. Am J Obstet Gynecol 2000; 183:1361.</a></li></ol></div><div id="topicVersionRevision">Topic 8080 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23633316" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Surgical management of pelvic organ prolapse in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8694033" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Current clinical nomenclature for description of pelvic organ prolapse</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28333818" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Practice Bulletin No. 176: Pelvic Organ Prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8987926" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14710089" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Adoption of the pelvic organ prolapse quantification system in peer-reviewed literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20052574" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Use of pelvic organ prolapse staging systems in published articles of selected specialized journals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16052294" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A comparison of preoperative and intraoperative evaluation of patients undergoing pelvic reconstructive surgery for pelvic organ prolapse using the Pelvic Organ Prolapse Quantification System.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20936258" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The inter-system association between the simplified pelvic organ prolapse quantification system (S-POP) and the standard pelvic organ prolapse quantification system (POPQ) in describing pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17766624" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : ACOG Practice Bulletin No. 85: Pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31833996" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Measuring Pelvic Floor Disorder Symptoms Using Patient-Reported Instruments: Proceedings of the Consensus Meeting of the Pelvic Floor Consortium of the American Society of Colon and Rectal Surgeons, the International Continence Society, the American Urogynecologic Society, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11744914" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18799443" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Prevalence of symptomatic pelvic floor disorders in US women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14710061" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Patient-selected goals: a new perspective on surgical outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15295366" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Patient-centered goals for pelvic floor dysfunction surgery: long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16522404" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10862835" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Effect of patient position on clinical evaluation of pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19387526" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Validation of the pelvic organ prolapse quantification (POP-Q) system in left lateral position.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12851759" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Effects of examination technique modifications on pelvic organ prolapse quantification (POP-Q) results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8293594" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Clinical evaluation of women with pelvic support defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9609331" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Vaginal topography does not correlate well with visceral position in women with pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9609331" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Vaginal topography does not correlate well with visceral position in women with pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21431391" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Multicenter inter-examiner agreement trial for the validation of simplified POPQ system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20728072" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Quantification of vaginal support: are continuous summary scores better than POPQ stage?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18165404" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The role of apical vaginal support in the appearance of anterior and posterior vaginal prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18165404" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The role of apical vaginal support in the appearance of anterior and posterior vaginal prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18165404" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The role of apical vaginal support in the appearance of anterior and posterior vaginal prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27921161" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27921161" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22678559" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Study of dynamic magnetic resonance imaging in diagnosis of pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19271092" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : A systematic review of clinical studies on dynamic magnetic resonance imaging of pelvic organ prolapse: the use of reference lines and anatomical landmarks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29944912" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Dynamic Pelvic Magnetic Resonance Imaging Evaluation of Pelvic Organ Prolapse Compared to Physical Examination Findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30082146" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Ultrasound in the assessment of pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11744905" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Correlation of symptoms with location and severity of pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18828990" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15746674" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12851756" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Symptoms, bother and POPQ in women referred with pelvic organ prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18185903" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32619717" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Clinical Characteristics and Postoperative Symptoms of 85 Adolescents with Endometriosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15932869" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Urinary incontinence in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12114887" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Predicting postoperative voiding efficiency after operation for incontinence and prolapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18060956" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing after transvaginal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11120497" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Postoperative resolution of urinary retention in patients with advanced pelvic organ prolapse.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
